Serum CD109 levels reflect the node metastasis status in head and neck squamous cell carcinoma.
Sumitaka HagiwaraEiichi SasakiYasuhisa HasegawaHidenori SuzukiDaisuke NishikawaShintaro BeppuHoshino TeradaMichi SawabeMasahide TakahashiNobuhiro HanaiPublished in: Cancer medicine (2021)
The serum CD109 levels were elevated in patients with advanced stage disease, reflecting the node metastasis status. CD109 in sera could be a novel prognostic marker for HNSCC involving lymph node metastasis.